Injectable peptides, compounds sold online and promoted on social media for anti-ageing and cosmetic purposes, are not TGA-approved therapeutic goods for cosmetic injection in Australia. Their safety profile in human cosmetic use is not established by peer-reviewed evidence. Core Aesthetics uses only Schedule 4 prescription medicines that are TGA-approved and individually prescribed. This article is general patient education. It is not medical advice.
In early 2026, a new injectable trend is circulating on social media and in online wellness communities. Injectable peptides, compounds including GHK-Cu, BPC-157, and TB-500, among others, are being promoted for anti-ageing, skin repair, and a range of cosmetic and physical enhancement claims. The content is confident, the sourcing is online, and the practitioners administering these products span a wide range of qualifications.
This article is not an advertisement for or against any particular product or trend. It is a clinical overview of what injectable peptides are, where they sit in the Australian regulatory framework, and what patients considering any form of injectable treatment should understand before making a decision.
Core Aesthetics uses only TGA-approved Schedule 4 prescription medicines, prescribed and administered by Corey Anderson, AHPRA registered nurse (NMW0001047575). The position here is simple: if a substance is not TGA-approved for the intended use, it is not used.
What Injectable Peptides Are
Peptides are short chains of amino acids, the building blocks of proteins. The human body produces peptides naturally; they are involved in a wide range of biological functions including wound healing, immune response, hormone signalling, and cellular regulation.
Some peptides have legitimate medical research applications. BPC-157, for example, has been studied in animal models for gastrointestinal healing and tissue repair. GHK-Cu appears in research related to skin wound healing. TB-500 has been investigated in animal models of cardiac repair.
The leap from animal-model research to ‘inject this into your face at a beauty clinic’ is a significant one, and it is being made commercially without the clinical evidence base that TGA approval requires. The mechanisms by which these compounds are hypothesised to work in humans are not yet established by peer-reviewed human clinical trials for cosmetic application.
The Australian Regulatory Gap
In Australia, medicines for injection are regulated by the Therapeutic Goods Administration (TGA). Cosmetic injectables administered by registered health practitioners, anti-wrinkle treatments and dermal fillers, are Schedule 4 prescription medicines. They require a prescription from an authorised prescriber, a consultation, and administration by a registered health practitioner in a clinical setting.
Injectable peptides being sold online and promoted on social media do not fall into this regulatory category. Many are sold as research chemicals or peptide compounds without therapeutic claims, a framing that places them outside standard TGA oversight of listed medicines, while also meaning they lack the safety and efficacy data that TGA approval requires.
This is not a technicality. The regulatory framework exists because injection of compounds directly into the body bypasses the normal absorption barriers that protect against adverse reactions. A compound that has not passed the TGA’s assessment for injectable human use has not had its safety profile, purity standards, or correct dosing established for that context.
UNSW’s April 2026 analysis of the injectable peptide trend notes the absence of human clinical trial evidence for the anti-ageing claims being made. The Conversation published the same analysis in the same week. Both are worth reading if you are considering this category of product.
Why This Is Relevant to Cosmetic Injectable Patients
Patients researching cosmetic injectables in Australia in 2026 may encounter peptide injection services being offered alongside or instead of TGA-approved cosmetic treatments. They may be offered by aestheticians, wellness practitioners, or people who are not registered health practitioners. They may be offered in beauty salons, via home visits, or through online subscription services.
The clinical concerns are specific. Any injection carries the risk of infection, vascular injury, and adverse reaction. These risks are managed in clinical settings by registered practitioners with the training and equipment to respond to adverse events. In non-clinical settings, they are not.
The absence of TGA approval for a compound is an absence of evidence, not simply a regulatory technicality. Patients considering any injectable product are entitled to ask: is this TGA-approved for this use in Australia? Is the person administering it a registered health practitioner? Is there a consultation before any injection takes place? These are the same questions to ask about any cosmetic injectable.
Core Aesthetics is a clinical injectable practice. The treatments offered here are TGA-approved prescription medicines, prescribed individually at consultation by Corey Anderson, AHPRA registered nurse. The basis for that choice is clinical, not commercial.
Questions to Ask Before Any Injectable Treatment
Whether you are considering a TGA-approved cosmetic injectable or anything else, these are the questions that protect your safety:
Is this product TGA-approved for this use in Australia? Not approved overseas. Not approved in general. Approved in Australia for this specific application.
Is the person administering it a registered health practitioner? You can check AHPRA registration at ahpra.gov.au. Registration is publicly searchable. If the person cannot be found, they are not registered.
Is there a consultation before the injection? A consultation is the point at which medical history, contraindications, and suitability are assessed. No responsible clinical injectable practice performs treatment without a prior consultation.
What is the clinical response plan if something goes wrong? Registered clinical practitioners are required to have appropriate emergency equipment and training to manage adverse events. Ask what the protocol is.
These questions apply to all injectables, including the treatments Corey Anderson offers. Transparency about the regulatory and clinical basis of any injectable treatment is the standard by which a practice should be judged.
A Note on Core Aesthetics’ Practice
Core Aesthetics is a TGA-compliant cosmetic injectable clinic. The treatments available here are prescription anti-wrinkle treatment and prescription dermal filler, both individually assessed at a consultation with Corey Anderson, AHPRA registered nurse (NMW0001047575, registered since January 1996).
No injectable peptides or non-TGA-approved compounds are used, offered, or endorsed at Core Aesthetics. This is a clinical position based on regulatory compliance and patient safety, not a marketing claim.
If you are considering cosmetic injectable treatment and want to understand what you are being offered before committing to it, a consultation at Core Aesthetics is available. The consultation will tell you what treatment is or is not appropriate for your situation, including whether treatment is not recommended at this time.
Is this for you?
Consider booking a consultation if
- Patients who have heard about injectable peptides and want a clinically grounded overview
- Patients wanting to understand the regulatory difference between TGA-approved cosmetic injectables and non-approved compounds
- Anyone considering any injectable treatment and wanting to ask the right safety questions
This may not be for you if
- This is a general information article and does not replace a consultation with a qualified health practitioner
- Pregnant or breastfeeding patients (active treatment is generally deferred)
- People with an active infection or skin condition affecting the treatment area
- Anyone with a known allergic reaction to similar product types
Suitability is confirmed at consultation. This list is general guidance, not a substitute for clinical assessment.
Frequently asked questions
Are injectable peptides legal in Australia?
The regulatory position is nuanced. Some peptides are listed as Schedule 4 or Schedule 8 medicines in Australia; others are sold as research chemicals outside the therapeutic goods framework. ‘Legal’ is not the same as ‘TGA-approved for cosmetic injection’. Patients should ask whether the specific compound being offered is TGA-approved for the specific use being proposed, not whether it is legal in general.
Can a beauty therapist or aesthetician legally inject peptides in Victoria?
Injection of prescription medicines in Victoria requires registration as a nurse, doctor, dentist, or similarly authorised health practitioner under AHPRA. Injecting prescription substances without appropriate registration is a criminal offence. Some peptides being marketed are not classified as prescription medicines, which creates a legal grey area, but an unregulated product in an unregulated setting does not have the same safety oversight as a TGA-approved medicine administered by a registered practitioner.
Is there any evidence that injectable peptides work for cosmetic purposes?
Current published research involves animal models and some in-vitro work. As of 2026, there are no peer-reviewed human clinical trials establishing the safety and efficacy of the specific peptide compounds currently trending on social media for cosmetic anti-ageing purposes. The absence of evidence is not evidence of safety or efficacy, it is a gap that the TGA approval process is designed to fill.
Why doesn’t Core Aesthetics offer peptide treatments?
Core Aesthetics uses only TGA-approved Schedule 4 prescription medicines. Compounds without TGA approval for their intended use are not offered regardless of trend or demand. This is a regulatory compliance position and a clinical safety position. Corey Anderson has 30 years of clinical nursing experience and approaches the use of any injectable product based on its established safety and efficacy profile.
What is the TGA and why does it matter for cosmetic injectables?
The Therapeutic Goods Administration (TGA) is Australia’s regulatory authority for therapeutic goods including medicines for injection. TGA approval of a medicine for a specific use means that the product has met the TGA’s standards for quality, safety, and efficacy in that use. Prescription cosmetic injectables, anti-wrinkle treatment and dermal filler, are Schedule 4 medicines approved and regulated by the TGA. This approval framework exists specifically to protect patients from harms associated with injectable substances that have not been properly assessed.
How is suitability for this treatment determined?
Suitability is decided through individual consultation with Corey Anderson, AHPRA registered nurse. Anatomy, medical history, prior treatments and the realistic outcomes of treatment are all reviewed before any decision is made.
What happens if treatment is not appropriate?
If the assessment finds that treatment is not appropriate, that conclusion is part of the consultation outcome. Results vary between individuals, and the consultation may identify reasons to defer, alter, or decline the treatment plan.
Are cosmetic injectables prescription medicines in Australia?
Yes. All cosmetic injectables used at Core Aesthetics are prescription medicines in Australia and can only be administered by an AHPRA registered health practitioner following individual clinical assessment.